SCHEMBL5372103

SCHEMBL5372103

COC(=O)c1cc(S(=O)(=O)Nc2ccc(-c3cc(C(F)(F)F)cc(C(F)(F)F)c3)cc2)ccc1C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.53
PLAU P00749 5/20 0.51
PLAT P00750 2/20 0.51
PSEN1 P49768 5/20 0.50
PSEN2 P49810 5/20 0.50
APH1B Q8WW43 5/20 0.50
NCSTN Q92542 5/20 0.50
APH1A Q96BI3 5/20 0.50
PSENEN Q9NZ42 5/20 0.50
CYP2D6 P10635 4/20 0.50
MEN1 O00255 1/20 0.49
ALOX15 P16050 1/20 0.49
MAPK1 P28482 1/20 0.49
KMT2A Q03164 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.47
HSD17B2 P37059 1/20 0.47
CYP3A4 P08684 2/20 0.45
BRD4 O60885 1/20 0.45
AVPR2 P30518 1/20 0.45
GPR27 Q9NS67 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5371871 0.93 MEN1 (0.57) POLBPLAUPLATPSEN1PSEN2
SCHEMBL5376420 0.91 PLAU (0.64) POLBPLAUPLATMEN1ALOX15
SCHEMBL5380381 0.89 POLB (0.61) POLBPLAUPLATPSEN1PSEN2
SCHEMBL5368389 0.86 POLB (0.60) POLBPLAUPLATSMN1; SMN2IDH1
SCHEMBL5378704 0.85 POLB (0.56) POLBPLAUMEN1KMT2ASMN1; SMN2
SCHEMBL5380693 0.84 POLB (0.62) POLBPLAUPLATMEN1MAPK1
SCHEMBL5376639 0.83 POLB (0.56) POLBPLAUPLATPSEN1PSEN2
SCHEMBL5391352 0.83 POLB (0.47) POLBPSEN1PSEN2APH1BNCSTN
SCHEMBL5386615 0.82 POLB (0.50) POLBPLAUPLATMEN1ALOX15
SCHEMBL5373250 0.82 POLB (0.63) POLBMEN1ALOX15MAPK1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PFIZER INC 2006-11-16 US disclosed
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD POLB 1807/4885PLAU 3190/4885PLAT 317/4885
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARG, PPARA, PPARD POLB 2006/4885PLAU 3215/4885PLAT 405/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.